Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
publishDate:"[2021 TO 2021]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=%22Medical+Condition%3A+Covid19%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=%22Medical+Condition%3A+Covid19%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=publishDate%3A%22%5B2021+TO+2021%5D%22&lookfor=%22Medical+Condition%3A+Covid19%22&type=Subject
PubPharm (275)
1
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 : An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 (VASCEPA-COVID-19)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
2
A randomised controlled trial of Dexamethasone for Emergency and Life-Threatening Admissions due to COVID-19 in Virtual Care: the DELTA study : A randomised controlled trial of Dexamethasone for Emergency and Life-Threatening Admissions due to COVID-19 in Virtual Care: the DELTA study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
A randomised controlled trial of Dexamethasone for Emergency and Life-Threatening Admissions due to COVID-19 in Virtual Care: the DELTA study : A randomised controlled trial of Dexamethasone for Emergency and Life-Threatening Admissions due to COVID-19 in Virtual Care: the DELTA study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) : A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Atovaquone for Treatment of COVID-19 : Atovaquone for Treatment of COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
6
Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat : A Randomized, Single Blind, Placebo-controlled, Multiple Dose, Parallel-arm Study to Investigate the Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat to Treat COVID-19 ("NICCAM")
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 : Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
MK-4482 Ph 2/3 Study in Hospitalized Participants with COVID-19 : A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19 - MK-4482 Ph 2/3 Study in Hospitalized Adults with COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
MK-4482 Ph 2/3 Study in Hospitalized Participants with COVID-19 : A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults with COVID-19 - MK-4482 Ph 2/3 Study in Hospitalized Adults with COVID-19
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients : IGHID 12021 - A Randomized, Phase II Study Comparing the Efficacy and Safety of Standard Versus High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Plasma in Hospitalized Patients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Erscheinungsjahr: 2021-2021
Medienart
275
Aufsätze
275
E-Artikel
275
E-Ressourcen
Zeitschriftentitel
153
ClinicalTrials.gov
122
WHO International Clinical Trials Registry Plat...
Thema
275
610
Phase: Phase 2
275
Study Type: Interventional
73
Recruitment Status: Not yet recruiting
72
Recruitment Status: Completed
56
Medical Condition: COVID-19
54
Recruitment Status: Authorised-recruitment may ...
41
COVID-19
36
Medical Condition: Covid19
33
Recruitment Status: Recruiting
18
Medical Condition: COVID-19 MedDRA version: 23....
18
Pneumonia
15
Coronavirus Infections
14
Recruitment Status: Terminated
14
Recruitment Status: Withdrawn
12
Infection
11
Recruitment Status: Active, not recruiting
10
Medical Condition: COVID-19 MedDRA version: 23....
10
Medical Condition: COVID-19 MedDRA version: 23....
10
Medical Condition: COVID-19 pneumonia and impai...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2021-2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
275
Englisch
Haven't found what you're looking for?
Wird geladen...